Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The prefrontal cortex (PFC) attentional control networks comprise a distributed system of brain regions, including the dorsolateral prefrontal cortex (dlPFC), anterior cingulate cortex (ACC), and frontal eye fields (FEF), that coordinate top-down attention and executive functions (1.3.1, 1.3.3). These networks are essential for goal-directed behavior, allowing individuals to focus on task-relevant stimuli while suppressing irrelevant distractions through the maintenance of representations in working memory (1.1.2, 1.1.3). Biological functions of these networks are heavily modulated by catecholamines, specifically norepinephrine and dopamine, which optimize the signal-to-noise ratio of neuronal firing (1.2.1, 1.4.1). Dysfunction within these circuits is a hallmark of various neuropsychiatric conditions, including attention-deficit/hyperactivity disorder (ADHD), schizophrenia, and major depressive disorder (1.3.2, 1.3.4). Therapeutic strategies often involve pharmacological agents like guanfacine or stimulants that target specific receptors (e.g., alpha-2A adrenoceptors) or transporters within the PFC to restore network efficiency (1.4.1, 1.4.2). Beyond pharmacology, these networks are also primary targets for neuromodulatory interventions such as transcranial magnetic stimulation (TMS).
Modulation of catecholamine signaling (norepinephrine and dopamine) to enhance synaptic connectivity and signal-to-noise ratio in the prefrontal cortex, often via alpha-2A adrenergic receptor agonism or inhibition of norepinephrine and dopamine transporters.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Prefrontal cortex attentional control networks.